Pharmacogenomics-Guided Antidepressant Therapy as a Solution to Treatment-Resistant Depression: A Systematic Review
Aims: Treatment-resistant depression (TRD), defined as failure to achieve remission despite adequate antidepressant trials, remains a pervasive clinical conundrum, linked to reduced quality of life, increased mortality, and higher healthcare costs. Pharmacogenomics-guided treatment (PGT) offers a po...
Saved in:
| Main Author: | Leah Rose Alexander |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-06-01
|
| Series: | BJPsych Open |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2056472425101919/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of pharmacogenomics-guided treatment on medication adherence and the antidepressant switching rate in major depressive disorder
by: Chaoli Chen, et al.
Published: (2024-11-01) -
Optimization of antidepressant treatment by pharmacogenomics: a case report
by: Ying Zhang, et al.
Published: (2025-01-01) -
Insomnia and Esketamine Add-On Therapy to Antidepressant Therapy in Patients with Treatment-Resistant Depression—A Pilot Study
by: Daniel Szawarnoga, et al.
Published: (2025-07-01) -
Clinically actionable pharmacogenomic landscape of antidepressants and antipsychotics in Qatar: a population-based cohort study
by: Dinesh Velayutham, et al.
Published: (2025-01-01) -
Quantifying the level of difficulty to treat major depressive disorder with antidepressants: Treatment Resistance to Antidepressants Evaluation Scale.
by: Tzu-Yu Liu, et al.
Published: (2020-01-01)